Sonic: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to Immunomodulators and biologic therapy

被引：36
|
作者：
Sandborn, W.
Rutgeerts, P.
Reinisch, W.
Kornbluth, A.
Lichtiger, S.
D'Haens, G.
van der Woude, C.
Diamond, R.
Broussard, D.
Colombel, J.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium
[3] Univ Hosp Vienna, Vienna, Austria
[4] Mt Sinai Med Ctr, New York, NY 10029 USA
[5] Imelda Ziekenhuis, Bonheiden, Belgium
[6] Erasmus MC, Rotterdam, Netherlands
[7] Centocor Inc, Horsham, PA USA
[8] CHU Lille, F-59037 Lille, France
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-01117
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1117
引用
收藏
页码：S436 / S436
页数：1
相关论文
共 50 条
  • [41] Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease
    Seddik, M
    Melliez, H
    Seguy, D
    Viget, N
    Cortot, A
    Colombel, JF
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (06) : 620 - 622
  • [42] Evolution of Endoscopic Activity Scores in Patients With Crohn's Disease Under Azathioprine and/or Infliximab: A Post-Hoc Analysis of the Sonic Data
    Ferrante, Marc
    Colombel, Jean-Frederic
    Sandborn, William J.
    Reinisch, Walter
    Mantzaris, Gerassimos J.
    Kornbluth, Asher
    Rachmilewitz, Daniel
    Lichtiger, Simon
    D'Haens, Geert R.
    Diamond, Robert
    Oortwijn, Alessandra Faria
    Tang, Kezhen L.
    van der Woude, Christien J.
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2011, 140 (05) : S422 - S422
  • [43] Higher levels of infliximab may alleviate the need of azathioprine comedication in the treatment of patients with Crohn's disease: a SONIC post hoc analysis
    Colombel, J. -F.
    Adedokun, O. J.
    Gasink, C.
    Tang, K.
    Cornillie, F.
    D'Haens, G.
    Rutgeerts, P.
    Reinisch, W.
    Sandborn, W.
    Hanauer, S.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S135 - S136
  • [44] Infliximab Infusion Patterns in Patients with Crohn's Disease Naive to Biologic Therapy: An Analysis of a National Health Plan
    Mueller, C. Schmeichel
    Denny, L.
    Tkacz, J.
    Reutsch, C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S412 - S412
  • [45] Infliximab therapy for patients with moderate to severe hidradenitis, suppurativa: A randomized, double-blind, placebo-controlled crossover trial
    Grant, Annika
    Gonzalez, Tayler
    Montgomery, Michael O.
    Cardenas, Vanessa
    Kerdel, Francisco A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (02) : 205 - 217
  • [46] PHASE III RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL TO COMPARE BIOSIMILAR INFLIXIMAB (CT-P13) WITH INNOVATOR INFLIXIMAB (INX) IN PATIENTS WITH ACTIVE CROHN'S DISEASE: EARLY EFFICACY AND SAFETY RESULTS
    Kim, Young Ho
    Ye, Byong Duk
    Pesegova, Marina
    Alexeeva, Olga
    Osipenko, Marina
    Lahat, Adi
    Dorofeyev, Andrey
    Salamon, Agnes
    Fishman, Sigal
    Levchenko, Olena
    Cheon, Jae Hee
    Scribano, Maria L.
    Mateescu, Radu-Bogdan
    Lee, Kang-Moon
    Eun, Chang Soo
    Lee, Sang Joon
    Lee, Sung Young
    GASTROENTEROLOGY, 2017, 152 (05) : S65 - S65
  • [47] A randomized, douuble-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
    Lémann, M
    Mary, JY
    Colombel, JF
    Duclos, B
    Soule, JC
    Lerebours, E
    Modigliani, R
    Bouhnik, Y
    GASTROENTEROLOGY, 2005, 128 (07) : 1812 - 1818
  • [48] A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis
    Naveau, S
    Chollet-Martin, S
    Dharancy, S
    Mathurin, P
    Jouet, P
    Piquet, MA
    Davion, T
    Oberti, F
    Broët, P
    Emilie, D
    HEPATOLOGY, 2004, 39 (05) : 1390 - 1397
  • [49] A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis
    Schiffenbauer, Adam
    Garg, Megha
    Castro, Christine
    Pokrovnichka, Angelina
    Joe, Galen
    Shrader, Joseph
    Cabalar, Imelda Victoria
    Faghihi-Kashani, Sara
    Harris-Love, Michael O.
    Plotz, Paul H.
    Miller, Frederick W.
    Gourley, Mark
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 47 (06) : 858 - 864
  • [50] Economic impact of combination therapy with infliximab plus azathioprine for drug-refractory Crohn's disease: A cost-effectiveness analysis
    Saito, Shota
    Shimizu, Utako
    Nan, Zhang
    Mandai, Nozomu
    Yokoyama, Junji
    Terajima, Kenshi
    Akazawa, Kouhei
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (02): : 167 - 174
12345